RTI Biologics, Inc. (RTIX) Tops Q4 EPS by 1c; Issues Light FY12 Outlook, Guides Q1

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

January 31, 2012 8:03 AM EST
RTI Biologics, Inc. (NASDAQ: RTIX) reported Q4 EPS of $0.04, $0.01 better than the analyst estimate of $0.03. Revenue for the quarter came in at $42.9 million versus the consensus estimate of $41.24 million.

RTI Biologics, Inc. sees FY2012 EPS of $0.15-$0.17, versus the consensus of $0.18. RTI Biologics, Inc. sees FY2012 revenue of $174-$176 million, versus the consensus of $175.84 million.

RTI Biologics, Inc. sees Q1 2012 EPS of $0.03, versus the consensus of $0.04. RTI Biologics, Inc. sees Q1 2012 revenue of $41-$42 million, versus the consensus of $42.46 million.

For earnings history and earnings-related data on RTI Biologics, Inc. (RTIX) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings